Resultats de la cerca - Akash Patnaik

Refinar resultats
  1. 1
    Ubiquitin is part of the retrovirus budding machinery

    Ubiquitin is part of the retrovirus budding machinery per Akash Patnaik, Vincent Chau, John W. Wills

    Publicat 2000
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    New Strategies in Prostate Cancer: Targeting Lipogenic Pathways and the Energy Sensor AMPK

    New Strategies in Prostate Cancer: Targeting Lipogenic Pathways and the Energy Sensor AMPK per Giorgia Zadra, Carmen Priolo, Akash Patnaik, Massimo Loda

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Targeting Innate Immunity in Cancer Therapy

    Targeting Innate Immunity in Cancer Therapy per Srikrishnan Rameshbabu, Brian Labadie, Anna Argulian, Akash Patnaik

    Publicat 2021
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Mouse Models for Cancer Immunotherapy Research

    Mouse Models for Cancer Immunotherapy Research per Brian M. Olson, Yadi Li, Yu Lin, Edison T. Liu, Akash Patnaik

    Publicat 2018
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    The APL Paradigm and the “Co-Clinical Trial” Project

    The APL Paradigm and the “Co-Clinical Trial” Project per Caterina Nardella, Andrea Lunardi, Akash Patnaik, Lewis C. Cantley, Pier Paolo Pandolfi

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors

    A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors per Renata Ferrarotto, Gail Eckhardt, Akash Patnaik, Patricia LoRusso, L. Faoro, John V. Heymach, Ann M. Kapoun, Lu Xu, P.N. Munster

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN/p53-deficient Aggressive-variant Prostate Cancer via Macrophage Phagocytosis

    Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN/p53-deficient Aggressive-variant Prostate Cancer via Macrophage Phagocytosis per Kiranj Chaudagar, Hanna M. Hieromnimon, Anne Kelley, Brian Labadie, Jordan Shafran, Srikrishnan Rameshbabu, Catherine Drovetsky, Kaela Bynoe, Ani Solanki, Erica Markiewicz, Xiaobing Fan, Massimo Loda, Akash Patnaik

    Publicat 2023
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial

    Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial per Padmanee Sharma, Russell K. Pachynski, Vivek Narayan, Aude Fléchon, Gwénaëlle Gravis, Matthew D. Galsky, Hakim Mahammedi, Akash Patnaik, Sumit K. Subudhi, Marika Ciprotti, Burçin Şimşek, Abdel Saci, Yanhua Hu, G. Celine Han, Karim Fizazi

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Preliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC): Updated analyses

    Preliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC): Updated an... per Wassim Abida, David Campbell, Akash Patnaik, Brieuc Sautois, Jeremy Shapiro, Nicholas J. Vogelzang, Alan H. Bryce, Ray McDermott, Francesco Ricci, Julie Rowe, Jie Zhang, Andrew D. Simmons, Darrin Despain, Matthew Dowson, Tony Golsorkhi, S. Chowdhury

    Publicat 2019
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer

    ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer per Shuai Gao, Huihui Ye, Sean Gerrin, Hongyun Wang, Ankur Sharma, Sen Chen, Akash Patnaik, Adam G. Sowalsky, Olga Voznesensky, Wanting Han, Ziyang Yu, Elahe A. Mostaghel, Peter S. Nelson, Mary-Ellen Taplin, Steven P. Balk, Changmeng Cai

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer

    A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer per Elena Garralda, Ammar Sukari, Nehal J. Lakhani, Akash Patnaik, Yiyun Lou, Seock‐Ah Im, Talia Golan, Ravit Geva, Martin Wermke, Maria J. de Miguel, J. Palcza, S. Jha, Marya Chaney, Anson K. Abraham, Jasmine Healy, Gerald S. Falchook

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations

    Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombinat... per Wassim Abida, Alan H. Bryce, Nicholas J. Vogelzang, R. J. Amato, Ivor Percent, Julia Shapiro, Ray McDermott, Arif Hussain, Akash Patnaik, Daniel P. Petrylak, Charles J. Ryan, T. Stanton, Jie Zhang, Andrew D. Simmons, Darrin Despain, Marnie Collins, T. Golsorskhi, Howard I. Scher, S. Chowdhury

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup> F-DCFPyL in Prostate Cancer Patients (OSPREY)

    A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup> F-DCFPyL in Prostate Cancer Patients (OSPREY) per Kenneth J. Pienta, Michael A. Gorin, Steven P. Rowe, Peter R. Carroll, Fréderic Pouliot, Stephan Probst, Lawrence Saperstein, Mark A. Preston, Ajjai Alva, Akash Patnaik, Jeremy C. Durack, Nancy Stambler, Tess Lin, Jessica Jensen, Vivien Wong, Barry A. Siegel, Michael J. Morris

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib

    Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib per Andrea Loehr, Arif Hussain, Akash Patnaik, Alan H. Bryce, Daniel Castellano, Albert Font, Jeremy Shapiro, Jingsong Zhang, Brieuc Sautois, Nicholas J. Vogelzang, Gurkamal Chatta, Kevin D. Courtney, Andrea Harzstark, Francesco Ricci, Darrin Despain, Simon P. Watkins, Charmin King, Minh Nguyen, Andrew D. Simmons, Simon Chowdhury, Wassim Abida

    Publicat 2022
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Vulnerabilities of <i>PTEN</i>–<i>TP53</i>-Deficient Prostate Cancers to Compound PARP–PI3K Inhibition

    Vulnerabilities of <i>PTEN</i>–<i>TP53</i>-Deficient Prostate Cancers to Compound PARP–PI3K Inhibition per Enrique González‐Billalabeitia, Nina Seitzer, Su Jung Song, Min Sup Song, Akash Patnaik, Xuesong Liu, Mirjam T. Epping, Antonella Papa, Robin M. Hobbs, Ming Chen, Andrea Lunardi, Christopher Ng, Kaitlyn A. Webster, Sabina Signoretti, Massimo Loda, John M. Asara, Caterina Nardella, John G. Clohessy, Lewis C. Cantley, Pier Paolo Pandolfi

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer

    A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer per Andrea Lunardi, Ugo Ala, Mirjam T. Epping, Leonardo Salmena, John G. Clohessy, Kaitlyn A. Webster, Guocan Wang, Roberta Mazzucchelli, Maristella Bianconi, Edward C. Stack, Rosina T. Lis, Akash Patnaik, Lewis C. Cantley, Glenn J. Bubley, Carlos Cordón-Cardo, William L. Gerald, Rodolfo Montironi, Sabina Signoretti, Massimo Loda, Caterina Nardella, Pier Paolo Pandolfi

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism

    Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism per Sarah‐Maria Fendt, Eric L. Bell, Mark A. Keibler, Shawn M. Davidson, Grégory J. Wirth, Brian P. Fiske, Jared R. Mayers, Matthias Schwab, Gary Bellinger, Alfredo Csibi, Akash Patnaik, Marie Jose Blouin, Lewis C. Cantley, Leonard Guarente, John Blenis, Michaël Pollak, Aria F. Olumi, Matthew G. Vander Heiden, Gregory Stephanopoulos

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Reversal of Lactate and PD-1–mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer

    Reversal of Lactate and PD-1–mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer per Kiranj Chaudagar, Hanna M. Hieromnimon, Rimpi Khurana, Brian Labadie, Taghreed Hirz, Shenglin Mei, Raisa Hasan, Jordan Shafran, Anne Kelley, Eva Apostolov, Ghamdan Al‐Eryani, Kate Harvey, Srikrishnan Rameshbabu, Mayme Loyd, Kaela Bynoe, Catherine Drovetsky, Ani Solanki, Erica Markiewicz, Marta Zamora, Xiaobing Fan, Stephan C. Schürer, Alexander Swarbrick, David B. Sykes, Akash Patnaik

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium

    Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consort... per Channing J. Paller, Emmanuel S. Antonarakis, Tomasz M. Beer, Hala T. Borno, Maria I. Carlo, Daniel J. George, Julie N. Graff, Shilpa Gupta, Elisabeth I. Heath, Celestia S. Higano, Rana R. McKay, Alicia K. Morgans, Akash Patnaik, Daniel P. Petrylak, Matthew B. Rettig, Charles J. Ryan, Mary‐Ellen Taplin, Young E. Whang, Jacob Vinson, Heather H. Cheng, Veda N. Giri

    Publicat 2019
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study

    Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Stud... per Wassim Abida, David Campbell, Akash Patnaik, Jeremy Shapiro, Brieuc Sautois, Nicholas J. Vogelzang, Éric Voog, Alan H. Bryce, Ray McDermott, Francesco Ricci, Julie Rowe, Jingsong Zhang, Josep M. Piulats, Karim Fizazi, Axel S. Merseburger, Celestia S. Higano, Laurence E. Krieger, Charles J. Ryan, Felix Y. Feng, Andrew D. Simmons, Andrea Loehr, Darrin Despain, Melanie Dowson, Foad Green, Simon P. Watkins, Tony Golsorkhi, Simon Chowdhury

    Publicat 2020
    Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:

Eines de cerca: